Historical epidemiology of hepatitis C virus in select countries—volume 4
Date
2017-07
Journal Title
Journal ISSN
Volume Title
Publisher
John Wiley & Sons Ltd.
Abstract
Due to the introduction of newer, more efficacious treatment options, there is a pressing
need for policy makers and public health officials to develop or adapt national
hepatitis C virus (HCV) control strategies to the changing epidemiological landscape.
To do so, detailed, country-specific
data are needed to characterize the burden of
chronic HCV infection. In this study of 17 countries, a literature review of published
and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution,
liver transplants and diagnosis and treatment rates was conducted, and inputs
were validated by expert consensus in each country. Viraemic prevalence in this study
ranged from 0.2% in Hong Kong to 2.4% in Taiwan, while the largest viraemic populations
were in Nigeria (2 597 000 cases) and Taiwan (569 000 cases). Diagnosis, treatment
and liver transplant rates varied widely across the countries included in this
analysis, as did the availability of reliable data. Addressing data gaps will be critical for
the development of future strategies to manage and minimize the disease burden of
hepatitis C.
Description
An article published by John Wiley & Sons Ltd.and available at DOI: 10.1111/jvh.12762
SUPPLEMENT A R T
Keywords
diagnosis, disease burden, epidemiology, HCV, hepatitis C, historical, incidence, mortality, prevalence, treatment
Citation
J Viral Hepat. 2017;24(Suppl. 2):8–24.